Improved Tumor Control Following Radiosensitization with Ultrasound-Sensitive Oxygen Microbubbles and Tumor Mitochondrial Respiration Inhibitors in a Preclinical Model of Head and Neck Cancer
暂无分享,去创建一个
Ankit K. Rochani | Ji-Bin Liu | M. Wheatley | F. Forsberg | D. Leeper | B. Oeffinger | J. Curry | J. Eisenbrey | P. O’Kane | S. Keith | G. Kaushal | A. Rochani | Quezia Lacerda | C. Wessner | Hebah A Falatah | Brian E. Oeffinger
[1] Jianliang Shen,et al. Metabolic reprogramming mediated PD-L1 depression and hypoxia reversion to reactivate tumor therapy. , 2022, Journal of controlled release : official journal of the Controlled Release Society.
[2] Jianliang Shen,et al. Killing Three Birds with One Stone: Multi-stage Metabolic Regulation Mediated by Clinically Usable Berberine Liposome to Overcome Photodynamic Immunotherapy Resistance , 2022, Chemical Engineering Journal.
[3] Jianliang Shen,et al. Tumor Selective Metabolic Reprogramming as a Prospective PD‐L1 Depression Strategy to Reactivate Immunotherapy , 2022, Advanced materials.
[4] V. Grégoire,et al. Biomarkers of radioresistance in head and neck squamous cell carcinomas , 2022, International journal of radiation biology.
[5] Ankit K. Rochani,et al. Tumoral Oxygenation and Biodistribution of Lonidamine Oxygen Microbubbles Following Localized Ultrasound-Triggered Delivery. , 2022, International journal of pharmaceutics.
[6] Wen-qing Luo,et al. Cascade two-stage tumor re-oxygenation and immune re-sensitization mediated by self-assembled albumin-sorafenib nanoparticles for enhanced photodynamic immunotherapy , 2022, Acta pharmaceutica Sinica. B.
[7] Corinne E. Wessner,et al. Development of a Dual Drug-Loaded, Surfactant-Stabilized Contrast Agent Containing Oxygen , 2022, Polymers.
[8] Q. Lei,et al. D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1 , 2022, Proceedings of the National Academy of Sciences.
[9] T. Fenton,et al. HPV-associated oropharyngeal cancer: epidemiology, molecular biology and clinical management , 2022, Nature Reviews Clinical Oncology.
[10] M. Brown,et al. Characteristic differences in radiation‐induced DNA damage response in human papillomavirus‐negative and human papillomavirus‐positive head and neck cancers with accumulation of fractional radiation dose , 2021, Head & neck.
[11] L. Qi,et al. Metformin Liposome-Mediated PD-L1 Downregulation for Amplifying the Photodynamic Immunotherapy Efficacy. , 2021, ACS applied materials & interfaces.
[12] Ji-Bin Liu,et al. US-triggered Microbubble Destruction for Augmenting Hepatocellular Carcinoma Response to Transarterial Radioembolization: A Randomized Pilot Clinical Trial. , 2020, Radiology.
[13] Ankit K. Rochani,et al. LC-MS based stability-indicating method for studying the degradation of lonidamine under physical and chemical stress conditions , 2020, Research in pharmaceutical sciences.
[14] M. Borden,et al. Phospholipid Oxygen Microbubbles for Image-Guided Therapy , 2020, Nanotheranostics.
[15] Ji Hyeon Kim,et al. Unimolecular Photodynamic O2-Economizer to Overcome Hypoxia Resistance in Phototherapeutics. , 2020, Journal of the American Chemical Society.
[16] Ji-Bin Liu,et al. Breast Cancer Brain Metastasis Response to Radiation After Microbubble Oxygen Delivery in a Murine Model , 2019, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[17] M. Wheatley,et al. Preserving the Integrity of Surfactant-Stabilized Microbubble Membranes for Localized Oxygen Delivery. , 2019, Langmuir : the ACS journal of surfaces and colloids.
[18] W. Bu,et al. Modulating Hypoxia via Nanomaterials Chemistry for Efficient Treatment of Solid Tumors. , 2018, Accounts of chemical research.
[19] Sha X. Chang,et al. Oxygen microbubbles improve radiotherapy tumor control in a rat fibrosarcoma model – A preliminary study , 2018, PloS one.
[20] Ji-Bin Liu,et al. Localized microbubble cavitation-based antivascular therapy for improving HCC treatment response to radiotherapy. , 2017, Cancer letters.
[21] Ji-Bin Liu,et al. Sensitization of hypoxic tumors to radiation therapy using ultrasound sensitive oxygen microbubbles , 2017, 2017 IEEE International Ultrasonics Symposium (IUS).
[22] J. Willmann,et al. Ultrasound-guided drug delivery in cancer , 2017, Ultrasonography.
[23] R. Zhou,et al. Mechanism of antineoplastic activity of lonidamine. , 2016, Biochimica et biophysica acta.
[24] H. Endou,et al. Metformin enhances anti-tumor effect of L-type amino acid transporter 1 (LAT1) inhibitor. , 2016, Journal of pharmacological sciences.
[25] Abdel Kareem Azab,et al. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy , 2015, Hypoxia.
[26] A. Levy,et al. Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives. , 2015, Cancer treatment reviews.
[27] John F. Callan,et al. Oxygen carrying microbubbles for enhanced sonodynamic therapy of hypoxic tumours. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[28] Ji-Bin Liu,et al. Development of an ultrasound sensitive oxygen carrier for oxygen delivery to hypoxic tissue. , 2015, International journal of pharmaceutics.
[29] Wei-Wei Zhang,et al. Metformin decreases IL‐22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma , 2014, International journal of cancer.
[30] Nathan D. Legband,et al. Systemic oxygen delivery by peritoneal perfusion of oxygen microbubbles , 2014, Biomaterials.
[31] Matthew G. Vander Heiden,et al. Metabolic targets for cancer therapy , 2013, Nature Reviews Drug Discovery.
[32] Ming Yan,et al. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma , 2012, BMC Cancer.
[33] Gregory J. Czarnota,et al. Tumor radiation response enhancement by acoustical stimulation of the vasculature , 2012, Proceedings of the National Academy of Sciences.
[34] E. S. Tolentino,et al. Oral adverse effects of head and neck radiotherapy: literature review and suggestion of a clinical oral care guideline for irradiated patients , 2011, Journal of applied oral science : revista FOB.
[35] Sara Rockwell,et al. Hypoxia and radiation therapy: past history, ongoing research, and future promise. , 2009, Current molecular medicine.
[36] N. Aaronson,et al. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[37] S. Lehnert,et al. Biomolecular Action of Ionizing Radiation , 2007 .
[38] Jens Overgaard,et al. Hypoxic radiosensitization: adored and ignored. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] D. Brizel,et al. Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[40] J. Brown,et al. Exploiting tumour hypoxia in cancer treatment , 2004, Nature Reviews Cancer.
[41] Andreas Dietz,et al. Predictive Value of the Tumor Oxygenation by Means of pO2 Histography in Patients with Advanced Head and Neck Cancer , 2001, Strahlentherapie und Onkologie.
[42] M. Dewhirst,et al. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[43] B. Silvestrini,et al. Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells. , 1981, Journal of the National Cancer Institute.
[44] J. Hendry,et al. Radiobiology for the Radiologist , 1979, British Journal of Cancer.